In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

Manual of Clinical Microbiology.

1980 • 14,937 citations

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

2002 • 1,370 citations

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

2004 • 907 citations

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

2004 • 651 citations

Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

2003 • 503 citations

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates

2005 • 405 citations

Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors

1997 • 321 citations

Caspofungin

2003 • 280 citations

Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases

2002 • 254 citations

Multiechinocandin- and Multiazole-ResistantCandida parapsilosisIsolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis

2005 • 243 citations

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

2004 • 238 citations

Caspofungin: the first representative of a new antifungal class

2003 • 211 citations

Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species

2004 • 172 citations

Caspofungin Resistance inCandida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis

2004 • 162 citations

The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy

2003 • 139 citations

Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies

1996 • 139 citations

Caspofungin: An echinocandin antifungal agent

2002 • 120 citations

Further Standardization of Broth Microdilution Methodology for In Vitro Susceptibility Testing of Caspofungin against Candida Species by Use of an International Collection of More than 3,000 Clinical Isolates

2004 • 89 citations

High Diversity of Group A Streptococcal emm Types in an Indian Community: The Need to Tailor Multivalent Vaccines

2004 • 82 citations

Caspofungin: first approved agent in a new class of antifungals

2003 • 77 citations

Candida glabrata Endophthalmitis Treated Successfully with Caspofungin

2005 • 69 citations

Micafungin: A New Echinocandin Antifungal

2006 • 65 citations

Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study

2004 • 62 citations

Influences of Methodological Variables on Susceptibility Testing of Caspofungin against Candida Species and Aspergillus fumigatus

2003 • 62 citations

Harmonization of antimicrobial breakpoints in Europe — Can it be achieved?

2004 • 45 citations

Refractory Candidal Meningitis in an Immunocompromised Patient Cured by Caspofungin

2004 • 43 citations

Anidulafungin: an echinocandin antifungal

2004 • 35 citations

Deleted Work

1955 • 0 citations